For stable atrial fibrillation with rapid ventricular response, what is the preferred acute rate-control option?

Prepare for the Platinum Emergency Medical Technician - Paramedic (EMTP) 3.3 Test. Engage with interactive questions and detailed explanations. Ace your EMT-P certification!

Multiple Choice

For stable atrial fibrillation with rapid ventricular response, what is the preferred acute rate-control option?

Controlling the ventricular rate quickly in stable atrial fibrillation with rapid ventricular response is the main goal. Slowing conduction through the AV node reduces the heart rate and improves symptoms, helping the heart work more efficiently during the AF episode. An IV nondihydropyridine calcium channel blocker, such as diltiazem given as 0.25 mg/kg over 2 minutes, is a classic first-line choice for acute rate control because it directly slows AV nodal conduction, typically producing a rapid reduction in ventricular rate. This approach is fast-acting, with the option to administer a second dose if needed, and is well-suited for stable patients. Adenosine is not ideal here because it’s used to reveal or terminate certain supraventricular tachycardias by transiently blocking AV nodal conduction, but it does not reliably slow the rate in atrial fibrillation and can cause uncomfortable or misleading effects. Synchronized cardioversion targets rhythm, not rate, and is reserved for unstable patients or when rate-control strategies fail; in a stable patient, rate control comes first. Digoxin has a slower onset and is less effective for acute rate control, though it may have a role in certain chronic scenarios, it’s not the best choice for rapid control of the ventricular rate in the ED.

Controlling the ventricular rate quickly in stable atrial fibrillation with rapid ventricular response is the main goal. Slowing conduction through the AV node reduces the heart rate and improves symptoms, helping the heart work more efficiently during the AF episode. An IV nondihydropyridine calcium channel blocker, such as diltiazem given as 0.25 mg/kg over 2 minutes, is a classic first-line choice for acute rate control because it directly slows AV nodal conduction, typically producing a rapid reduction in ventricular rate. This approach is fast-acting, with the option to administer a second dose if needed, and is well-suited for stable patients.

Adenosine is not ideal here because it’s used to reveal or terminate certain supraventricular tachycardias by transiently blocking AV nodal conduction, but it does not reliably slow the rate in atrial fibrillation and can cause uncomfortable or misleading effects. Synchronized cardioversion targets rhythm, not rate, and is reserved for unstable patients or when rate-control strategies fail; in a stable patient, rate control comes first. Digoxin has a slower onset and is less effective for acute rate control, though it may have a role in certain chronic scenarios, it’s not the best choice for rapid control of the ventricular rate in the ED.

More practice questions